Repurposing Siponimod for Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Alzheimer Disease · Mild Alzheimer Disease · MCI With Increased Risk for Alzheimer Disease · Cognitive Impairment, Mild

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Contact: Study coordinator (Connie Hillis) · connie.hillis@commonspirit.org · 602-406-5128
Contact: Principal Investigator (Marwan Sabbagh, MD)

Study leads

Marwan N Sabbagh, MD
Principal Investigator
St. Josep's Hospital and Medical Center, Phoenix
Boris Decourt, PhD
Study Chair
Texas Tech University Health Sciences Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Agitation · Alzheimer Disease

Abroad (travel likely)RecruitingPHASE2

Homewood, United States · Huntsville, United States

Neurologic Stem Cell Treatment Study

Neurologic Disorders · Nervous System Diseases · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Westport, United States · Coral Springs, United States

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Alzheimer Disease · Dementia · Plaque, Amyloid

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Huntington Beach, United States

Fisetin in Mild Alzheimer's Disease

Alzheimer s Disease · Alzheimer Dementia · Alzheimer Dementia (AD)

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada